{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:13:37Z","timestamp":1784646817862,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00014 and Options 15A, 15B and 17A"],"award-info":[{"award-number":["75N93021C00014 and Options 15A, 15B and 17A"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2021-67015-33406"],"award-info":[{"award-number":["2021-67015-33406"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01325-4","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:55:15Z","timestamp":1764244515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sequential aerosol and oral immunization with a bivalent H9N2\/H5N2 vaccine protects against H5N1 and H9N2 avian influenza challenges"],"prefix":"10.1038","volume":"10","author":[{"given":"Flavio","family":"Cargnin Faccin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Claire","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikshya","family":"Regmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hoelzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa D.","family":"Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Kapczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"1325_CR1","doi-asserted-by":"publisher","first-page":"e0042425","DOI":"10.1128\/jvi.00424-25","volume":"99","author":"Z Xie","year":"2025","unstructured":"Xie, Z. et al. Clade 2.3.4.4b highly pathogenic avian influenza H5N1 viruses: knowns, unknowns, and challenges. J. Virol. 99, e0042425 (2025).","journal-title":"J. Virol."},{"key":"1325_CR2","doi-asserted-by":"publisher","first-page":"2347019","DOI":"10.1080\/21645515.2024.2347019","volume":"20","author":"F Cargnin Faccin","year":"2024","unstructured":"Cargnin Faccin, F. & Perez, D. R. Pandemic preparedness through vaccine development for avian influenza viruses. Hum. Vaccin Immunother. 20, 2347019 (2024).","journal-title":"Hum. Vaccin Immunother."},{"key":"1325_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/nyas.12462","volume":"1323","author":"RG Webster","year":"2014","unstructured":"Webster, R. G. & Govorkova, E. A. Continuing challenges in influenza. Ann. N. Y Acad. Sci. 1323, 115\u2013139 (2014).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"1325_CR4","doi-asserted-by":"crossref","unstructured":"Carnaccini, S. & Perez, D. R. H9 influenza viruses: an emerging challenge. Cold Spring Harb Perspect Med. 10, a038588 (2020).","DOI":"10.1101\/cshperspect.a038588"},{"key":"1325_CR5","doi-asserted-by":"crossref","unstructured":"Peacock, T. H. P., James, J., Sealy, J. E. & Iqbal, M. A Global perspective on H9N2 avian influenza virus. Viruses 11, 620 (2019).","DOI":"10.3390\/v11070620"},{"key":"1325_CR6","doi-asserted-by":"crossref","unstructured":"Dong, J., Zhou, Y., Pu, J. & Liu, L. Status and challenges for vaccination against avian H9N2 influenza virus in China. Life 12, 1326 (2022).","DOI":"10.3390\/life12091326"},{"key":"1325_CR7","doi-asserted-by":"crossref","unstructured":"Obadan, A. O. et al. Flexibility in vitro of amino acid 226 in the receptor-binding site of an H9 Subtype influenza a virus and its effect in vivo on virus replication, tropism, and transmission. J. Virol. 93 e02011-18 (2019).","DOI":"10.1128\/JVI.02011-18"},{"key":"1325_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","volume":"9","author":"DS Rajao","year":"2018","unstructured":"Rajao, D. S. & Perez, D. R. Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture. Front. Microbiol. 9, 123 (2018).","journal-title":"Front. Microbiol."},{"key":"1325_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.20506\/rst.SE.3563","volume":"Special Edition","author":"DE Swayne","year":"2024","unstructured":"Swayne, D. E. et al. Strategic challenges in the global control of high pathogenicity avian influenza. Rev. Sci. Tech. Special Edition, 89\u2013102 (2024).","journal-title":"Rev. Sci. Tech."},{"key":"1325_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.20506\/rst.SE.3562","volume":"Special Edition","author":"LD Sims","year":"2024","unstructured":"Sims, L. D. Avian influenza: past, present and future. Rev. Sci. Tech. Special Edition, 83\u201388 (2024).","journal-title":"Rev. Sci. Tech."},{"key":"1325_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cimid.2008.01.006","volume":"32","author":"DE Swayne","year":"2009","unstructured":"Swayne, D. E. Avian influenza vaccines and therapies for poultry. Comp. Immunol. Microbiol. Infect. Dis. 32, 351\u2013363 (2009).","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"1325_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3382\/ps.2009-00093","volume":"89","author":"CJ Williams","year":"2010","unstructured":"Williams, C. J. & Zedek, A. S. Comparative field evaluations of in ovo applied technology. Poult. Sci. 89, 189\u2013193 (2010).","journal-title":"Poult. Sci."},{"key":"1325_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00923-y","volume":"9","author":"F Cargnin Faccin","year":"2024","unstructured":"Cargnin Faccin, F. et al. Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine. NPJ Vaccines 9, 136 (2024).","journal-title":"NPJ Vaccines"},{"key":"1325_CR14","doi-asserted-by":"crossref","unstructured":"Cardenas-Garcia, S. et al. FluB-RAM and FluB-RANS: genome rearrangement as safe and efficacious live attenuated influenza B virus vaccines. Vaccines 9, 897 (2021).","DOI":"10.3390\/vaccines9080897"},{"key":"1325_CR15","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1128\/JVI.02490-12","volume":"87","author":"L Pena","year":"2013","unstructured":"Pena, L. et al. Influenza viruses with rearranged genomes as live-attenuated vaccines. J. Virol. 87, 5118\u20135127 (2013).","journal-title":"J. Virol."},{"key":"1325_CR16","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3382\/ps\/pey011","volume":"97","author":"GA Albanese","year":"2018","unstructured":"Albanese, G. A., Tensa, L. R., Aston, E. J., Hilt, D. A. & Jordan, B. J. Evaluation of a coccidia vaccine using spray and gel applications. Poult. Sci. 97, 1544\u20131553 (2018).","journal-title":"Poult. Sci."},{"key":"1325_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/03079457.2017.1307941","volume":"46","author":"WJM Landman","year":"2017","unstructured":"Landman, W. J. M., Vervaet, C., Remon, J. P., Huyge, K. & van Eck, J. H. H. Primary Newcastle disease vaccination of broilers: comparison of the antibody seroresponse and adverse vaccinal reaction after eye-nose drop or coarse spray application, and implication of the results for a previously developed coarse dry powder vaccine. Avian Pathol. 46, 451\u2013461 (2017).","journal-title":"Avian Pathol."},{"key":"1325_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1637\/6094","volume":"47","author":"MW Jackwood","year":"2003","unstructured":"Jackwood, M. W., Hilt, D. A. & Brown, T. P. Attenuation, safety, and efficacy of an infectious bronchitis virus GA98 serotype vaccine. Avian Dis. 47, 627\u2013632 (2003).","journal-title":"Avian Dis."},{"key":"1325_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/vim.2017.0050","volume":"31","author":"MS Abdul-Cader","year":"2018","unstructured":"Abdul-Cader, M. S. et al. Hatchery vaccination against poultry viral diseases: potential mechanisms and limitations. Viral Immunol. 31, 23\u201333 (2018).","journal-title":"Viral Immunol."},{"key":"1325_CR20","doi-asserted-by":"crossref","unstructured":"Seibert, B. et al. Air-liquid interface model for influenza aerosol exposure in vitro. J. Virol. 99, e0061925 (2025).","DOI":"10.1128\/jvi.00619-25"},{"key":"1325_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-0716-3533-9_4","volume":"2733","author":"CJ Caceres","year":"2024","unstructured":"Caceres, C. J., Gay, L. C., Faccin, F. C. & Perez, D. R. Use of reverse genetics for the generation of recombinant influenza viruses carrying nanoluciferase. Methods Mol. Biol. 2733, 47\u201374 (2024).","journal-title":"Methods Mol. Biol."},{"key":"1325_CR22","doi-asserted-by":"publisher","first-page":"110715","DOI":"10.1016\/j.vetimm.2024.110715","volume":"268","author":"S Raj","year":"2024","unstructured":"Raj, S. et al. Efficacy of an inactivated influenza vaccine adjuvanted with Toll-like receptor ligands against transmission of H9N2 avian influenza virus in chickens. Vet. Immunol. Immunopathol. 268, 110715 (2024).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"1325_CR23","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1016\/j.vaccine.2021.09.028","volume":"39","author":"SJ Park","year":"2021","unstructured":"Park, S. J. et al. Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice. Vaccine 39, 6213\u20136220 (2021).","journal-title":"Vaccine"},{"key":"1325_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4142\/jvs.2016.17.1.27","volume":"17","author":"JH Shin","year":"2016","unstructured":"Shin, J. H., Mo, J. S., Kim, J. N., Mo, I. P. & Ha, B. D. Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens. J. Vet. Sci. 17, 27\u201334 (2016).","journal-title":"J. Vet. Sci."},{"key":"1325_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1325_CR26","doi-asserted-by":"crossref","unstructured":"Zimmermann, P. & Curtis, N. Factors that influence the immune response to vaccination. Clin. Microbiol. Rev. 32, e00084-18 (2019).","DOI":"10.1128\/CMR.00084-18"},{"key":"1325_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35586-7","volume":"13","author":"D Stadlbauer","year":"2022","unstructured":"Stadlbauer, D. et al. Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nat. Commun. 13, 7864 (2022).","journal-title":"Nat. Commun."},{"key":"1325_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.it.2023.11.001","volume":"45","author":"NC Wu","year":"2024","unstructured":"Wu, N. C. & Ellebedy, A. H. Targeting neuraminidase: the next frontier for broadly protective influenza vaccines. Trends Immunol. 45, 11\u201319 (2024).","journal-title":"Trends Immunol."},{"key":"1325_CR29","doi-asserted-by":"publisher","first-page":"954811","DOI":"10.3389\/fcimb.2022.954811","volume":"12","author":"A Nogales","year":"2022","unstructured":"Nogales, A., DeDiego, M. L. & Martinez-Sobrido, L. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. Front. Cell Infect. Microbiol. 12, 954811 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1325_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/QCO.0b013e328344c0e3","volume":"24","author":"S Wu","year":"2011","unstructured":"Wu, S., Metcalf, J. P. & Wu, W. Innate immune response to influenza virus. Curr. Opin. Infect. Dis. 24, 235\u2013240 (2011).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1325_CR31","doi-asserted-by":"crossref","unstructured":"Nagashima, K. A. & Mousa, J. J. Next-generation influenza HA immunogens and adjuvants in pursuit of a broadly protective vaccine. Viruses 13, 546 (2021).","DOI":"10.3390\/v13040546"},{"key":"1325_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1359-6101(00)00015-0","volume":"12","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12, 53\u201372 (2001).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1325_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1600-065X.2008.00668.x","volume":"225","author":"DE Swayne","year":"2008","unstructured":"Swayne, D. E. & Kapczynski, D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol. Rev. 225, 314\u2013331 (2008).","journal-title":"Immunol. Rev."},{"key":"1325_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.biologicals.2005.08.003","volume":"33","author":"DL Suarez","year":"2005","unstructured":"Suarez, D. L. Overview of avian influenza DIVA test strategies. Biologicals 33, 221\u2013226 (2005).","journal-title":"Biologicals"},{"key":"1325_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02460-2","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Sci. Rep. 7, 2193 (2017).","journal-title":"Sci. Rep."},{"key":"1325_CR36","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1128\/JVI.00893-07","volume":"81","author":"H Song","year":"2007","unstructured":"Song, H., Nieto, G. R. & Perez, D. R. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J. Virol. 81, 9238\u20139248 (2007).","journal-title":"J. Virol."},{"key":"1325_CR37","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1099\/vir.0.2008\/004143-0","volume":"89","author":"D Hickman","year":"2008","unstructured":"Hickman, D. et al. An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. J. Gen. Virol. 89, 2682\u20132690 (2008).","journal-title":"J. Gen. Virol."},{"key":"1325_CR38","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1016\/S0264-410X(02)00268-2","volume":"20","author":"E Hoffmann","year":"2002","unstructured":"Hoffmann, E., Krauss, S., Perez, D., Webby, R. & Webster, R. G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20, 3165\u20133170 (2002).","journal-title":"Vaccine"},{"key":"1325_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1006\/viro.1998.9318","volume":"249","author":"DR Perez","year":"1998","unstructured":"Perez, D. R. & Donis, R. O. The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. Virology 249, 52\u201361 (1998).","journal-title":"Virology"},{"key":"1325_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ REED","year":"1938","unstructured":"REED, L. J. & MUENCH, H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"1325_CR41","doi-asserted-by":"publisher","first-page":"e2419985122","DOI":"10.1073\/pnas.2419985122","volume":"122","author":"LM Ferreri","year":"2025","unstructured":"Ferreri, L. M. et al. Dispersal of influenza virus populations within the respiratory tract shapes their evolutionary potential. Proc. Natl. Acad. Sci. USA 122, e2419985122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1325_CR42","doi-asserted-by":"crossref","unstructured":"Caceres, C. J. et al. Development of a novel live attenuated influenza A virus vaccine encoding the IgA-inducing protein. Vaccines 9, 703 (2021).","DOI":"10.3390\/vaccines9070703"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01325-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:54:23Z","timestamp":1767063263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01325-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01325-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7402596\/v1","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}